GuidanceMHRA
Clinical trials for medicines: Diagnostic Radiopharmaceutical Investigation Medicinal Products and Good Manufacturing Practice requirements
Further explanatory guidance for Diagnostic Radiopharmaceutical (RP) Investigation Medicinal Products (IMPs) and Good Manufacturing Practice (GMP) requirements.
First published: Apr 27, 2026Last updated: Apr 27, 2026Changes: 1
Latest change: First published.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.